Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota

Mayo Clinic Proceedings

Volumn 70, Issue 8, 1995, Pages 725-733

  Gitter, Michael J ^a   Jaeger, Thomas M ^a   Petterson, Tanya M ^a   Gersh, Bernard J ^a   Silverstein, Marc D ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

INR; international normalized ratio

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOMYOPATHY; CHILD; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PEPTIC ULCER; POPULATION RESEARCH; RISK ASSESSMENT; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

EID: 0029081554     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/70.8.725     Document Type: Article

References (21)

1. Oral anticoagulant drugs
2. Hemorrhagic complications of anticoagulant treatment
3. Risk factors for complications of chronic anticoagulation: a multicenter study
4. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy
5. The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy
6. Aging and the anticoagulant response to warfarin therapy
7. Age-related risks of long-term oral anticoagulant therapy
8. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin
9. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
10. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
11. Stroke Prevention in Atrial Fibrillation Study: final results
12. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
13. Risk factors for thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study
14. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
15. The effect of warfarin on mortality and reinfarction after myocardial infarction
16. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy
17. Are older patients at increased risk for major bleeding during anticoagulant therapy? [abstract]
18. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Airial Fibrillation II Study
19. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment
20. Complications of long-term anticoagulation